Standard Biotools Inc. (NASDAQ:LAB)
Insiders here have filed 4 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
Loses money on what it sells.
- Revenue
- $84.6M
- Net income
- -$87.4M
- Net margin
- -103.3%
Little or no net debt.
- Total debt
- $28.1M
- Cash
- $270.0M
- Debt / equity
- 0.05
Comfortably covers what is due within a year.
- Current assets
- $516.9M
- Current liabilities
- $56.8M
- Current ratio
- 9.10
Consumes cash and must keep raising it.
- Operating cash flow
- -$80.3M
- Free cash flow
- -$82.6M
- FCF margin
- -97.6%
Not funding itself by issuing shares.
- Shares outstanding
- 390.9M
- Share growth (1y)
- 2.7%
- Cash runway
- 40 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
LAB Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 20.10 M | 21.15 M | 23.80 M | 19.55 M | 21.76 M | 20.22 M |
| Revenue Growth (YoY) | -7.62 % | 4.57 % | -49.07 % | -56.52 % | -3.25 % | -55.60 % |
| Cost of Revenue | 9.57 M | 9.84 M | 13.55 M | 10.07 M | 11.13 M | 9.17 M |
| Gross Profit | 10.54 M | 11.31 M | 10.24 M | 9.48 M | 10.63 M | 11.05 M |
| SG&A Expense | 16.39 M | 18.61 M | 24.38 M | 26.59 M | 28.11 M | 29.82 M |
| R&D Expense | 1.98 M | 2.12 M | 7.79 M | 6.36 M | 6.22 M | 5.44 M |
| Operating Expenses | 35.92 M | 20.72 M | 32.16 M | 32.95 M | 34.33 M | 35.26 M |
| Operating Income | -25.39 M | -9.42 M | -21.92 M | -23.47 M | -23.70 M | -24.21 M |
| Pretax Income | -21.43 M | -14.62 M | -22.03 M | -32.90 M | -18.28 M | -23.49 M |
| Tax Provision | 90.00 K | 11.00 K | -35.93 M | -1.22 M | -609.00 K | -119.00 K |
| Net Income | -26.76 M | -45.22 M | 19.28 M | -34.69 M | -33.46 M | -26.03 M |
| EPS (Basic) | -0.07 | -0.12 | 0.05 | -0.09 | -0.09 | -0.07 |
| EPS (Diluted) | -0.07 | -0.12 | 0.05 | -0.09 | -0.09 | -0.07 |
| Shares Outstanding | 390.88 M | 388.20 M | 385.05 M | 382.63 M | 380.50 M | 378.23 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.